(Reuters) - Health Canada approved 100-milligram, 200-milligram and
300-milligram tablets of the once-daily version for sale.
The go-ahead comes a little more than two weeks after
Labopharm said the U.S. Food and Drug Administration declined
to approve its tramadol formulation until further conditions
are met.
Read more at Reuters.com Government Filings News
300-milligram tablets of the once-daily version for sale.
The go-ahead comes a little more than two weeks after
Labopharm said the U.S. Food and Drug Administration declined
to approve its tramadol formulation until further conditions
are met.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment